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A. Aitouche, M.T. Rugeles, A. Zeevi, J.J. Fung, T.E. Starzl, and A.S. Rao 
T HE ubiquitous presence of donor cell chimerism in the 
tissues of long-term successful organ allograft recipi-
ents l - 3 provided quintessential support to the argument 
that these cells playa seminal role in allograft acceptance 
and in the induction of donor-specific tolerance. A finding 
of commensurate significance was the observation that 
livers (unlike other organs) when transplanted orthotopi-
cally across most mouse4 and several rat-strain combi-
nations5 •b and in few outbred pigs 7.H are spontaneously 
accepted without the necessity for exogenous immunosup-
pression. This ascertainment complemented by the novel 
observations made by Lu et at' has prompted the advance-
ment of the hypothesis that perhaps the comparative tolero-
genicity of various organs is contingent on the quantity and 
quality of resident migratory cells. of which those of den-
dritic leukocyte lineage conceivably play an auspicious role. 
Given their functional significance, we initiated a systematic 
search to establish the presence of progenitors of donor-
dendritic cells (DC) in the peripheral blood of bone marrow 
(BM)-augmented organ transplant recipients. Additionally, 
the evidence for the multilineage donor cell chimerism was 
also sought; reported herein is the outcome of these 
investigations. 
MATERIALS AND METHODS 
Peripheral Blood Mononuclear Cells (PBMC) 
PBMC were obtained from si.x BM-augmented organ transplant 
recipients who were at least 12 months' posttransplantation. For 
BM-augmentation. cells (6 x 1O"/kg body weight) obtained from 
the vertebral bodies of the cadaveric donor were infused intrave-
nously at the time of revascularization. PBMC from healthy normal 
volunteers served as standard controls for the propagation of DC 
(see below). 
Culture/Sorting of DC 
PBMC were cultured in AIM-V media supplemented with [-
glutamine for 2 hours at 37°C in 5% Cl~ in air. Nonadhercnt cells 
were subsequently removed and the adherent population was 
replenished with rhGM-CSF and rhIL-4-enrichcd medium. The 
cells were then cultured for an additional i\ to 12 days. with fresh 
medium being exchanged every 3 to .. days. 
At the end of this incubation. the nonadhercnt cells were 
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harvested and further purified by flotation over metrizamiue 
columns. A portion of these cells were used in primary MLR assays 
to determine their allostimulatory activity. The remaining cells 
were stained with a cocktail of PE-conjugated lineage (CD3/CD221 
CD56/CDI4)·specific and FlTC-colljugated anti-HLA-DR MAh. 
Lineagenull/DR T cells were sorted. and within them the presence of 
donor DNA was confirmed hy PCR analysis. 
Sorting of Lineage" Cells 
For the establishment of multilineage chimerism. PBMC ohtained 
from 8M-augmented recipients were stained with lineage-specific 
MAb and sorted. Within the sorted population. the presence of 
donor DNA was confirmed by PCR analysis. 
RESULTS AND DISCUSSION 
The cells harvested from proliferating cultures 8 to 12 days 
postincubation exhibited distinctive dendritic morphology. 
When tested in primary MLR. these cultured cells displayed 
very potent stimulatory capacity_ confirming their origin as 
that of dendritic leukocyte lineage. In 4 of 5 evaluated 
patients, the presence of donor DNA was confirmed in 
sorted DC by PCR. Additionally, donor DNA was also 
found in sorted lineage + cells. suggesting that chimerism is 
indeed multilineage. Although the presence of progenitors 
of donor DC in BM-augmented recipients years after 
transplantation provides unequivocal evidence for its en-
graftment. the functional significance of this finding. how-
ever, remains a subject for further investigation. 
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